Talk:2-MMC

From PsychonautWiki
Jump to navigation Jump to search
Yellow-warning-sign1.svg

This page has not been fully approved by the PsychonautWiki administrators.

It may contain incorrect information, particularly with respect to dosage, duration, subjective effects, toxicity and other risks. It may also not meet PW style and grammar standards.

Summary sheet: 2-MMC
2-MMC
2-MMC.svg
Chemical Nomenclature
Common names 2-MMC, Orthophedrone
Substitutive name 2-Methylmethcathinone
Systematic name 2-(methylamino)-1-phenylpropan-1-one
Class Membership
Psychoactive class Stimulant / Entactogen
Chemical class Cathinone
Routes of Administration

WARNING: Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. See responsible use section.






Insufflated
Dosage
Threshold 10 mg
Light 15 - 40 mg
Common 40 - 80 mg
Strong 50 - 100 mg
Heavy 100 mg +
Duration
Total 2.5 - 4.5 hours
Onset 5 - 10 minutes
Come up 10 - 20 minutes
Peak 1 - 1.5 hours
Offset 1 - 2 hours
After effects 1 - 1.5 hours





Intravenous
Dosage
Threshold 1 mg
Light 1 - 10 mg
Common 10 - 30 mg
Strong 30 - 50 mg
Heavy 50 mg +
Duration
Total 1 - 3 hours
Onset 1 - 10 seconds
Come up 5 - 10 minutes
Peak 15 - 30 minutes
Offset 30 - 45 minutes

DISCLAIMER: PW's dosage information is gathered from users and resources for educational purposes only. It is not a recommendation and should be verified with other sources for accuracy.

Interactions

2-Methylmethcathinone (also known as 2-MMC, Ortho or Orthomephedrone) is a novel lesser-known stimulant-entactogen substance of the cathinone class that induces feelings of euphoria, and stimulation. It is related to other substituted cathinones like for example 3-MMC or 4-MMC (Mephedrone). The mechanism of action is not fully studied, but dopamine ,serotonin and norepinephrine releasing activity is known to be involved.

2-MMC is shown to be more dopaminergic and less serotonergic compared to MDMA. This profile makes it more stimulating and less empathogenic, similar to that of Amphetamine.

Subjective effects include stimulation, anxiety suppression, enhanced empathy and sociability, relaxation, increased libido, increased music appreciation and euphoria. The effects are reported to be a mix of amphetamine and a cocaine-like stimulation rush with a lighter version of MDMA euphoria. It is highly advised to use harm reduction practices if using this substance as it has a very short history of use.

History and culture

It was first identified in Sweden in May 2014.[1]. Until recently, it had beeen an obscure substance, unclassified in many countries. Cases of its use were sporadic. However, since the Dutch ban on 3-MMC, the sale and use of 2-MMC became prevalent in the Netherlands.[citation needed]

Chemistry

2-Methylmethcathinone's chemical name is 2-(methylamino)-1-phenylpropan-1-one and is a cathinone derivative, which is a synthetic form of phenylethylamines. 2-MMC has a cathinone which is substituted with a methyl group at the 2 position which makes it a structural isomer of Metaphedrone.

Pharmacology

Pill bottle-o.png

This pharmacology section is incomplete.

You can help by adding to it.

Subjective effects

Disclaimer: The effects listed below cite the Subjective Effect Index (SEI), an open research literature based on anecdotal user reports and the personal analyses of PsychonautWiki contributors. As a result, they should be viewed with a healthy degree of skepticism.

It is also worth noting that these effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects. Likewise, adverse effects become increasingly likely with higher doses and may include addiction, severe injury, or death ☠.


Physical effects
Child.svg

Cognitive effects
User.svg

After effects
Aftereffects (3).svg

{{{2}}}

Experience reports

There are currently 1 experience reports which describe the effects of this substance in our experience index.

Additional experience reports can be found here:

Toxicity and harm potential

Ambulance2.png

This toxicity and harm potential section is a stub.

As a result, it may contain incomplete or even dangerously wrong information! You can help by expanding upon or correcting it.
Note: Always conduct independent research and use harm reduction practices if using this substance.

It is strongly recommended that one use harm reduction practices when using this substance.

Lethal dosage

Tolerance and addiction potential

Like other cathinones, 2-MMC remains a highly addictive substance

Dangerous interactions

Warning: Many psychoactive substances that are reasonably safe to use on their own can suddenly become dangerous and even life-threatening when combined with certain other substances. The following list provides some known dangerous interactions (although it is not guaranteed to include all of them).

Always conduct independent research (e.g. Google, DuckDuckGo, PubMed) to ensure that a combination of two or more substances is safe to consume. Some of the listed interactions have been sourced from TripSit.

  • 25x-NBOMe & 25x-NBOH - 25x compounds are highly stimulating and physically straining. Combinations with 2-MMC should be strictly avoided due to the risk of excessive stimulation and heart strain. This can result in increased blood pressure, vasoconstriction, panic attacks, thought loops, seizures, and heart failure in extreme cases.
  • Alcohol - Combining alcohol with stimulants can be dangerous due to the risk of accidental over-intoxication. Stimulants mask alcohol's depressant effects, which is what most people use to assess their degree of intoxication. Once the stimulant wears off, the depressant effects will be left unopposed, which can result in blackouts and severe respiratory depression. If mixing, the user should strictly limit themselves to only drinking a certain amount of alcohol per hour.
  • DXM - Combinations with DXM should be avoided due to its inhibiting effects on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers (MDMA, methylone, mephedrone, etc.). Monitor blood pressure carefully and avoid strenuous physical activity.
  • MDMA - Any neurotoxic effects of MDMA are likely to be increased when other stimulants are present. There is also a risk of excessive blood pressure and heart strain (cardiotoxicity).
  • MXE - Some reports suggest combinations with MXE may dangerously increase blood pressure and increase the risk of mania and psychosis.
  • Dissociatives - Both classes carry a risk of delusions, mania and psychosis, and these risk may be multiplied when combined.
  • Stimulants - 2-MMC may be dangerous to combine with other stimulants like cocaine as they can increase one's heart rate and blood pressure to dangerous levels.
  • Tramadol - Tramadol is known to lower the seizure threshold[3] and combinations with stimulants may further increase this risk.
  • Cocaine - This combination may increase strain on the heart.


Legal status

  • Germany: 2-MMC is controlled under the NpSG (New Psychoactive Substances Act)[4] as of November 26, 2016.[5] Production and import with the aim to place it on the market, administration to another person and trading is punishable. Possession is illegal but not penalized.[6]
  • Poland: Illegal in Poland, the substance is not included in the list of groups of psychotropic substances, however, it falls under the group of psychotropic substances of group I-P as isomer of 3-MMC (metaphedrone) and 4-MMC (mephedrone).

See also

External links

References

  1. "Europol 2014 Annual Report on the implementation of Council Decision 2005/387/JHA" (PDF). European Monitoring Centre for Drugs and Drug Addiction. 10 May 2005. 
  2. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0045473
  3. Talaie, H.; Panahandeh, R.; Fayaznouri, M. R.; Asadi, Z.; Abdollahi, M. (2009). "Dose-independent occurrence of seizure with tramadol". Journal of Medical Toxicology. 5 (2): 63–67. doi:10.1007/BF03161089. eISSN 1937-6995. ISSN 1556-9039. OCLC 163567183. 
  4. "Anlage NpSG" (in German). Bundesministerium der Justiz und für Verbraucherschutz. Retrieved December 19, 2019. 
  5. "Gesetz zur Bekämpfung der Verbreitung neuer psychoaktiver Stoffe" (PDF) (in German). Bundesanzeiger Verlag. Retrieved December 19, 2019. 
  6. "§ 4 NpSG" (in German). Bundesministerium der Justiz und für Verbraucherschutz. Retrieved December 19, 2019.